Pharmaceuticals: Cigna’s Express Scripts Takes Legal Action Against FTC

Tuesday, 17 September 2024, 12:57

Pharmaceuticals news highlights how Cigna’s PBM, Express Scripts, has filed a lawsuit against the FTC over the agency’s contentious drug-cost report. The allegations claim bias and defamation, seeking to retract the report's findings. As potential implications unfold, further scrutiny on regulation in healthcare services arises.

Marketwatch — Pharmaceuticals: Cigna’s Express Scripts Takes Legal Action Against FTC

Legal Action by Cigna’s PBM

Cigna Group's pharmacy benefit manager, Express Scripts, has initiated a lawsuit against the U.S. Federal Trade Commission (FTC) on allegations that a report issued in July about the PBM industry is biased and defamatory.

Details of the Lawsuit

The suit details demands for the court to compel the FTC to retract their controversial drug-cost report, which Express Scripts argues misrepresents the impact of PBM operations in the healthcare sector.

Implications for Regulation and Government Policy

This legal action sheds light on the ongoing tensions within the financial services sector involving regulation and government policy impacting the pharmaceuticals industry.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.